Day: Biotech
7 Questions
Rnatics: Hope for pulmonary fibrosis
Rnatics is developing RCS-21, a novel inhalable drug for pneumonia and idiopathic pulmonary fibrosis. The startup was founded in 2021 as a spin-off of…
Deals
Tubules purchased from American pharmaceutical giant
Munich-based biotech unicorn Tubulis is being sold to US corporation Gilead for a billion-dollar sum.
7 Questions
Rnhale: Inhalable RNA for new therapies
Munich-based biotech startup Rnhale is developing inhalable RNA therapeutics as a dry powder – faster, simpler, and more efficient than previous approaches. This is intended to treat respiratory diseases…
Deals
A milestone in the treatment of lung diseases? Rnatics receives 2.7 million euros.
Munich-based biotech startup Rnatics has secured €2.7 million in federal funding. The funds will be used for the clinical development of a…
Inside Stories
Twogee Biotech: Valuable materials from biomass
Twogee Biotech transforms industrial waste into sustainable sugar, thus turning biomass by-products into a valuable raw material for the chemical and biotechnology industries.
Deals
Twogee Biotech raises €2.16 million
Munich-based startup Twogee Biotech has secured multi-million euro seed funding. The company will use the capital to accelerate the industrial application of…
Deals
2NA Fish receives fresh capital
Munich-based startup 2NA Fish secures another pre-seed investment to advance its spatial RNA biomarker detection platform.
Competition
Biovaria launches new Pitch & Partner program 2026
Startups in the life sciences and biotechnology sectors, as well as founders, can now apply. Prize money of up to €2,000 and…
Deals
Amplifold raises 5 million euros
Munich-based startup Amplifold receives five million euros for the further development of its DNA origami technology, which is intended to make rapid medical tests significantly more sensitive.
Deals
Tubulis increases Series C to 344 million euros
Munich-based biotech company Tubulis has increased its Series C financing round from €308 million to €344 million, thereby accelerating its development…
Deals
Smartbax receives 4.7 million euros
The Munich-based biotech startup Smartbax has secured €4.7 million in a pre-Series A round. The team plans to use the capital to further develop its antibiotics…
Deals
Tubulis receives record sum of 308 million euros
Munich-based biotech Tubulis is working on special antibody drug conjugates (ADCs) for cancer therapy. The company has now secured €308 million in funding…
